An Extension Trial of Asedebart in Participants With Congenital Adrenal Hyperplasia

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The main goal of the trial is to study the long-term safety, how well people can handle the treatment, and how asedebart acts in the body and affects the body when used to treat classic congenital adrenal hyperplasia (CAH). The trial will include participants who have previously received asedebart in trial 19873A (NCT05669950).
Epistemonikos ID: 6b5c49ba36b77e7d7a1db79e27b4d4e9b8d096a6
First added on: Oct 06, 2026